Bedrock Pharmaceuticals Private Limited
About Bedrock Pharmaceuticals Private Limited
Data last updated:
Bedrock Pharmaceuticals Private Limited is a private limited company based in Rudrapur, Uttarakhand, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 06 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24304UR2019PTC010064. Its GSTIN is 05AAICB5808J1ZM (Uttarakhand).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Bhavin Harshadkumar Gandhi and Vishal Bhushan.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 18 Vimal Homes Bagwara, Rudrapur, Uttarakhand, India – 263153.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.71 Lakh, a growth of 26% compared to the previous year. For the same year it recorded a net loss of ₹2.84 Lakh (net margin -14.4%) and EBITDA of -₹2.81 Lakh (EBITDA margin -14.2%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 72% over five years.
Company details
Contact details
Bedrock Pharmaceuticals Private Limited's registered office is in Rudrapur, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered AddressH. No. 18 Vimal Homes Bagwara, Rudrapur, Uttarakhand, India – 263153
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Bedrock Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bedrock Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bedrock Pharmaceuticals Private Limited, buy the company report.
Financials of Bedrock Pharmaceuticals Private Limited
FY 2025 filings availableBedrock Pharmaceuticals Private Limited reported revenue of ₹19.71 Lakh (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 72% over five years, including 26% growth in the latest year. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14.2% | ||||
| Net Profit Margin | -14.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bedrock Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bedrock Pharmaceuticals Private Limited
Bedrock Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavin Harshadkumar Gandhi | Director | 06 Aug 2019 | 7 Years 3 Months | Current |
| Vishal Bhushan | Director | 06 Aug 2019 | 7 Years 3 Months | Current |
| Ankur Varshney | Director | 06 Aug 2019 | 7 Years 3 Months | Current |
Peer comparison
Bedrock Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Astrakind Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2024) | 275.0% | Jaipur, Rajasthan, India | |||
| Ridus Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Artenda Pharmaceuticals Private Limited | ₹19.71 Lakh (FY 2017) | 118.0% | Chennai, Tamil Nadu, India | |||
| Loenz Pharmaceuticals (OPC) Private Limited | ₹19.71 Lakh (FY 2021) | 302.0% | Saharsa, Bihar, India | |||
| Bedrock Pharmaceuticals Private Limitedthis company | ₹19.71 Lakh (FY 2025) | -₹2.84 Lakh | -14.4% | 26.0% | Rudrapur, Uttarakhand, India | |
| Alrosa Pharmaceuticals Private Limited | ₹19.64 Lakh (FY 2025) | -26.0% | Ambala, Haryana, India | |||
| Scotlin Pharmaceuticals Private Limited. | ₹19.63 Lakh (FY 2025) | 5.0% | Delhi, India |
To see the full peer comparison of Bedrock Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bedrock Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bedrock Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bedrock Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAICB5808J1ZM | Uttarakhand | Active | 20 Aug 2019 |
To see the full GST registrations and return filing status of Bedrock Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bedrock Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Ankur Varshney was appointed as Director on 06 Aug 2019.
Frequently asked questions
Bedrock Pharmaceuticals is an active private limited company based in Rudrapur, Uttarakhand, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 06 August 2019 (7+ years old) and is registered under CIN U24304UR2019PTC010064.
Bedrock Pharmaceuticals has 3 current directors:
- Bhavin Harshadkumar Gandhi - Director
- Vishal Bhushan - Director
- Ankur Varshney - Director
The latest financial statements of Bedrock Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Bedrock Pharmaceuticals is 05AAICB5808J1ZM, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Bedrock Pharmaceuticals is U24304UR2019PTC010064. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bedrock Pharmaceuticals was incorporated on 06 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Bedrock Pharmaceuticals by revenue are Astrakind Pharmaceuticals Private Limited, Ridus Pharmaceuticals Private Limited, Artenda Pharmaceuticals Private Limited, Loenz Pharmaceuticals (OPC) Private Limited, Alrosa Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ankur Varshney was appointed as Director on 06 Aug 2019. Bhavin Harshadkumar Gandhi was appointed as Director on 06 Aug 2019. Vishal Bhushan was appointed as Director on 06 Aug 2019.
The registered office of Bedrock Pharmaceuticals is at H. No. 18 Vimal Homes Bagwara, Rudrapur, Uttarakhand, India – 263153.
Bedrock Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
Bedrock Pharmaceuticals can be reached at its registered office: H. No. 18 Vimal Homes Bagwara, Rudrapur, Uttarakhand, India – 263153.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
